Mar 26, 2026 08:02AM
Mar 26, 2026 08:00AM
Nov 19, 2025 08:01AM
Nov 19, 2025 08:00AM
Mar 25, 2025 08:00AM
Mar 18, 2025 08:00AM
Mar 11, 2025 08:00AM Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Post-Traumatic Stress Disorder to take Place at Massachusetts General Hospital
Nov 19, 2024 08:02AM
Nov 19, 2024 08:00AM
Aug 26, 2024 08:04AM
Aug 26, 2024 08:00AM
Aug 19, 2024 08:06AM
Aug 19, 2024 08:00AM
Aug 12, 2024 08:03AM Alzamend Neuro (ALZN) Partners with Massachusetts General Hospital for a Phase II Clinical Trial of AL001
Aug 12, 2024 08:00AM
Aug 6, 2024 08:00AM
Aug 5, 2024 09:10AM
Aug 5, 2024 09:09AM
Dec 11, 2023 08:02AM
Dec 11, 2023 08:00AM
Nov 20, 2023 08:01AM Alzamend Neuro (ALZN) Receives FDA “Study May Proceed” Notification for a Phase IIA Trial of AL001
Nov 20, 2023 08:00AM
Nov 13, 2023 08:03AM
Nov 13, 2023 08:00AM
Oct 23, 2023 08:04AM
Oct 23, 2023 08:00AM
Oct 2, 2023 08:04AM
Oct 2, 2023 08:00AM Alzamend Neuro Receives FDA “Study May Proceed” Notification for a Phase IIA Clinical Trial of AL001, a Next-Generation Lithium Therapeutic Drug Candidate, in Bipolar Disorder Patients
Aug 30, 2023 08:05AM
Aug 30, 2023 08:00AM
Jun 22, 2023 08:05AM
Jun 22, 2023 08:00AM
Apr 3, 2023 08:04AM
Apr 3, 2023 08:00AM
Dec 28, 2022 08:00AM Alzamend Neuro Partners With the Miller School of Medicine, Interdisciplinary Stem Cell Institute at the University of Miami for ALZN002 Phase I/IIA Immunotherapy Vaccine Clinical Trial to Treat Mild
Nov 15, 2022 08:00AM
Nov 1, 2022 06:31AM
Nov 1, 2022 06:30AM
Oct 31, 2022 08:00AM
Oct 31, 2022 08:00AM
Oct 5, 2022 08:00AM
Sep 29, 2022 08:01AM Alzamend Neuro (ALZN) Submits IND Application for Phase I/IIA Trial for an Immunotherapy ALZN002
Sep 29, 2022 08:00AM
Jul 18, 2022 08:06AM
Jul 18, 2022 08:00AM
May 17, 2022 08:02AM
May 17, 2022 08:00AM
Apr 28, 2022 06:31AM
Apr 28, 2022 06:30AM BitNile Holdings Announces Additional Investment in Alzamend From Completion of Phase 1 First-in-Human Clinical Trial for AL001 Treatment of Dementia Related to Alzheimer’s
Apr 4, 2022 08:00AM

322,238 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All